Akeso Begins Phase II Trial of Bispecific ADC in Breast Cancer
Hong Kong, China, August 9, 2026 Akeso, Inc. has announced the first patient dosing in a Phase II clinical...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Hong Kong, China, August 9, 2026 Akeso, Inc. has announced the first patient dosing in a Phase II clinical...
Chicago, Illinois, USA, August 10, 2026 Beltone has announced Beltone Illuminateâ„¢, a new family of premium hearing aids designed...
WHITE BEAR LAKE, Minn., July 21, 2026 Envoy Medical announced that all 56 patients enrolled in its pivotal clinical...
LONE TREE, Colorado, July 13, 2026 Cochlear Limited, a global leader in implantable hearing solutions, has announced U.S. FDA...
